製品名:5,7-dichloro-3-isopropylpyrazolo[1,5-a]pyrimidine

IUPAC Name:5,7-dichloro-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidine

CAS番号:771510-32-8
分子式:C9H9Cl2N3
純度:95%+
カタログ番号:CM151764
分子量:230.09

包装単位 有効在庫 価格(USD) 数量
CM151764-100mg in stock ǯĽ
CM151764-250mg in stock ȀƄ
CM151764-1g in stock ȎĽȎ
CM151764-5g in stock ŢǯȀ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:771510-32-8
分子式:C9H9Cl2N3
融点:-
SMILESコード:CC(C)C1=C2N=C(Cl)C=C(Cl)N2N=C1
密度:
カタログ番号:CM151764
分子量:230.09
沸点:
MDL番号:MFCD12923044
保管方法:Store at 2-8°C.

Category Infos

Pyrazolopyrimidines
Pyrazolopyrimidine scaffolds are one of the most important heterocyclic compounds in drug discovery. This scaffold has various biological activities, among which anticancer is an important one.

Column Infos

Samuraciclib
Carrick Therapeutics’ Phase 2 Clinical Trial of Samuraciclib combined with Fulvestrant has dosed its first patient. The study targets patients with CDK4/6i resistant HR+, HER2- metastatic breast cancer. Samuraciclib is a selective oral, first-in-class inhibitor of CDK7. It is involved in the regulation of cancer-causing genes, promotion of uncontrolled cell cycle progression, and increase in resistance to anti-hormone therapy. The comb previously receives the Fast Track Designation from the U.S. FDA.

Related Products